ArticleCancer research communications2026
Community-Based Hereditary Breast and Ovarian Cancer Family History Assessment and Genetic Testing among Spanish-Speaking Hispanic/Latina Women in California.
Article in Cancer research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
Breast cancer is the most common cancer among women in the United States and the leading cause of cancer incidence and mortality among Hispanic/Latina (H/L) women. For women with a genetic predisposition to hereditary breast and ovarian cancer (HBOC), genetic counseling has been shown to aid in the decision-making process and engagement in risk-reducing strategies for cancer prevention and early detection. However, H/L women are less likely to receive genetic testing and undergo genetic counseling than non-Hispanic White women. We developed a promotores-led virtual HBOC outreach, education, and risk assessment program [Tu Historia Cuenta (THC)] for Spanish-speaking H/L women in California. In this study, we describe genetic testing uptake, testing results, and participants' experiences. Participants (N = 1,286) responded to a demographic and HBOC family history survey. Those identified as high risk based on the family history survey were offered free genetic testing with a hereditary cancer panel. Of the 111 women identified as high risk, 18 had been previously tested, and 33 received genetic testing through THC, resulting in a 35.5% completion rate for those offered testing. Among the 51 women with test results, 6 had a positive result, 3 were carriers of a variant of unknown significance, 38 had a negative result, and 4 participants tested before recruitment did not know their results. Participants who tested through THC indicated satisfaction with the genetic testing process. These findings underscore the importance of simplifying access and exploring additional factors influencing H/L women's decision to receive testing beyond previously established cost, awareness, and knowledge barriers. SIGNIFICANCE: Utilization of genetic testing and genetic counseling among H/L women in the United States remains limited. The promotores-led THC is one of the first community-based outreach programs for Spanish-speaking H/L women outside of a healthcare setting. Overcoming barriers such as language, cost, and knowledge, we identified additional obstacles such as testing kit activation and fear of future costs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.